Results from The Atrial Fibrillation Progression Trial (ATTEST), were presented on August 31st at the ESC* Congress 2019 in Paris, France. ATTEST is the first randomised controlled trial to directly compare the effectiveness of ablation...
Abiomed (NASDAQ: ABMD) announces today that the Impella CP® with SmartAssist technology, which is designed to improve patient outcomes with advanced algorithms and simplified patient management...
[Thread] |Anonymous Tip 8 Months Ago Suggested Stimwave Was Not Reporting MDR's. Now the #FDA is Investigating. @TheJusticeDept | https://t.co/fVrsyHspIM
— medtech[y] (@medtechy) August 30, 2019
Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of stenotic lesions...
Oticon, Inc. today introduced the world’s most powerful hearing aids to its portfolio of advanced hearing solutions. Designed for adults and children with severe-to-profound hearing loss, respectively, Oticon Xceed ...
Medtronic (NYSE:MDT) today announced that Omar Ishrak, Medtronic’s Chairman and Chief Executive Officer (CEO), has announced his intention to retire as CEO on April 26, 2020, following the end of the company’s current fiscal year....
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced that it is now selling its Micro Invasive suite of products in thirty countries worldwide....
Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that its Zephyr Valve is now covered by Priority Health® under its revised lung volume reduction coverage policy....
Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced it has completed enrollment in TRANSCEND, its pivotal clinical trial for the SurVeil drug-coated balloon (DCB)....
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system...